SRPT Sarepta Therapeutics, Inc.
$15.43▼ -2.89%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$1.63B
P/E Ratio
45.4
Div Yield
–%
52W Range
14.68 - 25.32
% vs 50 MA
-2.10%
% vs 200 MA
-13.19%
RSI-14
43.8
MACD Histogram
-0.2000
Beta (1Y vs SPY)
2.17
Gross Rev
$2.18B
Gross Profit
$470.80M
EBITDA
$46.18M
COGS
$1.71B
Operating Exp
$424.61M
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Jun 2026 (Quarterly)
Social Sentiment
Avg +0.50 · 38 posts
SRPT is going to $15 before it goes to $30
r/stocks · Apr 15, 2026
The post expresses a bearish sentiment regarding SRPT, citing negative events like deaths and clinical holds, and poor revenue, predicting further price declines.
negative
-0.60
TradeDiscussionEarningsCheap Calls, Puts and Earnings Plays for this week
r/options · Dec 15, 2025
Mentioned positively due to cheap options and favorable news.
positive
+0.60
TradeMemePriceTargetSRPT is mooning and there's nothing you can do about it
r/wallstreetbets · Oct 29, 2025
The author expresses extreme excitement and a belief that the stock is 'mooning,' indicating a strong bullish sentiment. Phrases like 'I'm boned' suggest a high degree of risk and reliance on the stock.
very_positive
+0.90
DDTradePriceTarget$SRPT big ole gap
r/wallstreetbets · Oct 10, 2025
The user expresses hope for a ‘gap up’ and a ‘beaten down stock’, indicating bullish sentiment.
positive
+0.80
DDTradePriceTarget$SRPT Gaping Gap
r/wallstreetbets · Oct 9, 2025
The post expresses optimism about SRPT filling a gap and rising in price.
positive
+0.80
Page 1 of 8 (38 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.